Human epidermal growth factor receptor (EGFR) and the EGFR variant (v) III mutation (EGFRvIII) are exosomal biomarkers that have been used for the early detection of fatal brain tumor glioblastoma from circulating blood. Here, EGFR is linked to glioblastoma.